STOCK TITAN

Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
Apyx Medical announces the Renuvion Users' Summit in Las Vegas, showcasing innovative research on Renuvion technology for cosmetic and plastic surgery. The summit features key opinion leaders presenting new data on body contouring, fat transfer, and safety of Renuvion, aiming to enhance patient outcomes and provide top-notch care.
Positive
  • None.
Negative
  • None.

Shaping the Future of Aesthetic Treatments with Advanced Medical Technology

CLEARWATER, Fla.--(BUSINESS WIRE)-- Apyx® Medical Corporation (NASDAQ:APYX) (the “Apyx Medical”; “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, is pleased to announce the Renuvion Users’ Summit is taking place in Las Vegas from April 12-13, 2024.

The Renuvion Users’ Summit brings together a diverse group of dedicated professionals in cosmetic and plastic surgery from 13 countries to share new research, applications, and clinical experiences with the Company’s Renuvion technology. The insights and innovation shared at the Renuvion Users’ Summit will help medical professionals provide the highest level of care for their patients seeking solutions to improve the appearance of loose skin through body contouring and other procedures.

The Renuvion Users’ Summit will feature 27 key opinion leader speakers who bring a deep knowledge and understanding of the Renuvion technology and how it can be used to enhance outcomes for patients. New data and research will be presented, with a focus on body contouring, fat transfer and the safety of Renuvion, including during the following presentations:

  • The Renuvion Effect: Using Ultrasound to Measure Tissue Contraction
  • Scarless Mastopexy: Pearls of Using the Renuvion Technology
  • Enhanced Fat Graft Viability Following Renuvion Pretreatment
  • Renuvion in High-Definition Liposuction: The European Concept of Beauty
  • The Back/Bra Roll: A Consistent and Reproducible Treatment with Renuvion

“The Renuvion Users’ Summit brings together some of the most brilliant minds in the cosmetic surgery market, all united with a single goal – to provide their patients with best-in-class care. It is designed to support our surgeon customers by providing them with access to new insights and research related to the use of our Renuvion technology,” said Charlie Goodwin, President, and CEO of Apyx Medical Corporation.

“Renuvion has transformed the lives of thousands of patients seeking solutions for loose skin worldwide,” said Dr. Paul G. Ruff, board-certified plastic surgeon and clinical research investigator for Apyx Medical. “The clinical data showcasing Renuvion's safety and efficacy is unmatched in the category, and the knowledge shared at the Renuvion Users’ Summit will continue to advance the science and ultimately benefit patients everywhere.”

Renuvion represents the pinnacle of propriety helium plasma and radiofrequency technology, designed to achieve tissue contraction by addressing the problem of loose skin directly at the source, ultimately providing patients with next level body contouring results. With six new FDA clearances and three exclusive indications, including the only post-liposuction use and subcutaneous tissue contraction clearances, Renuvion continues to set new standards in safety and performance.

About Apyx Medical Corporation

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.

Public Relations:

Kaplow Communications on behalf of Apyx Medical Corporation

Renuvion@kaplow.com

Investor Relations:

ICR Westwicke on behalf of Apyx Medical Corporation

Mike Piccinino, CFA

investor.relations@apyxmedical.com

Source: Apyx Medical Corporation

The Renuvion Users' Summit is scheduled to take place in Las Vegas from April 12-13, 2024.

The summit focuses on sharing new research, applications, and clinical experiences related to Apyx Medical's Renuvion technology in cosmetic and plastic surgery.

The summit will feature 27 key opinion leader speakers who have in-depth knowledge of the Renuvion technology.

Topics such as body contouring, fat transfer, and the safety of Renuvion will be discussed at the summit.

The summit aims to provide medical professionals with new insights and research to enhance patient care using Renuvion technology.
Apyx Medical Corporation

NASDAQ:APYX

APYX Rankings

APYX Latest News

APYX Stock Data

48.50M
24.98M
17.92%
48.15%
2.04%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
CLEARWATER

About APYX

apyx medical corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. it operates in two segments, advanced energy and original equipment manufacturing (oem). the company develops j-plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. it markets and sells helium plasma technology under the renuvion brand name in the cosmetic surgery market and under the j-plasma brand name in the hospital surgical market. the company's renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the j-plasma system allows surgeons to operate in eliminating unintended tissue trauma. it also designs, develops, manufactures, and sells electrosurgical and oem generators and related accessories for medical device manufacturers. the company was formerly known as bovie medical corporation and changed